About Prime Medicine, Inc.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Prime Medicine, Inc. (PRME) Stock Score & Signals
Prime Medicine, Inc. (PRME) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 31 out of 100.
2BB score and signals
Prime Medicine, Inc.’s current 2BB score is 31 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 50 | Normal |
| Quality | 100 | Very Strong |
| Risk | 0 | Very Low |
Company facts
| Founded | 2019 |
| Employees | 146 |
| 52-week range | $2.67 – $6.94 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.2519 | — | $1.42M |
| 2026-08-06 | — | -0.2625 | — | $1.32M |
| 2026-05-06 | — | -0.2549 | — | $677,790.00 |
| 2026-02-27 | — | -0.2564 | — | $2.39M |